明智选择印度:肿瘤诊疗中应避免的十项低价值或有害实践
明智选择印度运动旨在确定与印度肿瘤医疗体系相关的低价值或潜在有害实践。由印度国家癌症网格召集的多学科工作组采用框架驱动的共识流程,识别出十项在印度频繁实施的低价值或有害肿瘤实践,其中四项为全新推荐,六项为对既往明智选择美国及加拿大列表的修订或改编。
要点
- 十项实践涉及诊断与治疗(五项)、姑息治疗(两项)、影像(两项)及系统层面照护提供(两项)。
- 四项为全新推荐,六项为对明智选择美国及加拿大列表的修订或改编。
- 实施该列表并报告与其推荐的一致性,将促进印度提供高质量、基于价值的肿瘤照护。
核心结论
- 实施该列表并报告与其推荐的一致性,将促进印度提供高质量、基于价值的肿瘤照护。
研究设计与样本
- 明智选择印度运动通过多学科框架驱动的共识流程,识别与印度肿瘤医疗体系相关的低价值或潜在有害实践。
- 由印度国家癌症网格召集的工作组包括来自外科、内科和放射肿瘤学的印度代表,每个专科均有私营和公共部门代表。
- 工作组包括两名来自全国患者和患者倡导团体的代表。
主要发现
- 共识别出十项实践,其中四项为全新推荐,六项为对既往明智选择美国及加拿大列表的修订或改编。
- 最终列表中的推荐涉及诊断与治疗(五项实践)、姑息治疗(两项实践)、影像(两项实践)及系统层面照护提供(两项实践)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Choosing Wisely India campaign was an initiative that was established to identify low-value or potentially harmful practices that are relevant to the Indian cancer health-care system. We undertook a multidisciplinary framework-driven consensus process to identify a list of low-value or harmful cancer practices that are frequently undertaken in India. A task force convened by the National Cancer Grid of India included Indian representatives from surgical, medical, and radiation oncology. Each specialty had representation from the private and public sectors. The task force included two representatives from national patient and patient advocacy groups. Of the ten practices that were identified, four are completely new recommendations, and six are revisions or adaptations from previous Choosing Wisely USA and Canada lists. Recommendations in the final list pertain to diagnosis and treatment (five practices), palliative care (two practices), imaging (two practices), and system-level delivery of care (two practices). Implementation of this list and reporting of concordance with its recommendations will facilitate the delivery of high-quality, value-based cancer care in India.
引用
- Pramesh CS, Chaturvedi H, Reddy VA, et al. Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care. Lancet Oncol. 2019. PMID: 30857957. doi:10.1016/S1470-2045(19)30092-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。